Lepton Pharmaceuticals,  a pre-commercial-stage biopharmaceutical company focused on discovery and development of novel treatments for unmet medical needs, exploiting the subtle silencing of coding RNA expression by noncoding RNA molecules  microRNA (miRNA) , and small interfering RNA (siRNA) is pleased to announce that it completed the national phase filings for its international patent application PCT/IL2021/05142...

Lepton Pharmaceuticals LTD a pre-commercial-stage biopharmaceutical company focused on development proprietary gene editing based treatments for primarily oncology indications, is pleased to announce that it signed a Master Service Agreement with Reaction Biology for providing drug development services for advancing Lepton’s proprietary breakthrough Castling technology based novel treatments for oncology  indications. The Castling Technology is...